IBM Retirement Fund’s Haemonetics HAE Stock Holding History

IBM Retirement Fund’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,858	Closed	-$221K	–	781
2020 Q4	$221K	Buy	+1,858	New	+$200K	0.02%	726

Other funds holding HAE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IBM Retirement Fund's HAE Position: Q1 2021 in Review

IBM Retirement Fund sold out of Haemonetics (HAE) in Q1 2021, closing a stake of 1,858 shares — an estimated $221K sold.

IBM Retirement Fund first reported a position in HAE in Q4 2020 and held it in 1 quarter. The position peaked at $221K in Q4 2020. 296 funds tracked by Wall St. Rank hold HAE as of Q1 2021.

IBM Retirement Fund reported no remaining Haemonetics position as of Q1 2021 after selling out during the quarter.
IBM Retirement Fund sold 1,858 Haemonetics shares in Q1 2021, an estimated $221K.
IBM Retirement Fund first reported a position in Haemonetics in Q4 2020 and held it in 1 quarter.
IBM Retirement Fund's Haemonetics position peaked at $221K in Q4 2020.
296 funds tracked by Wall St. Rank held Haemonetics as of Q1 2021.

Based on IBM Retirement Fund's 13F filing for Q1 2021, filed 22 Apr 2021.